AFC-HD AMS Life Science Co., Ltd. provided earnings guidance for the year ending August 2023. For the period, the company expects net sales of ¥24,741 million, Operating profit of ¥1,481 million, and Profit attributable to owners of the parent of ¥687 million or ¥48.82 basic per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
891 JPY | +0.34% | +1.25% | +11.38% |
1st Jan change | Capi. | |
---|---|---|
+11.38% | 80.12M | |
+4.94% | 7.88B | |
+2.93% | 6.09B | |
-5.18% | 3.76B | |
-11.51% | 3.54B | |
-12.06% | 1.21B | |
-28.83% | 1.09B | |
+15.98% | 1B | |
-8.82% | 931M | |
-14.37% | 823M |
- Stock Market
- Equities
- 2927 Stock
- News AFC-HD AMS Life Science Co., Ltd.
- AFC-HD AMS Life Science Co., Ltd. Provides Earnings Guidance for the Year Ending August 2023